drugset / Trial / NCT03711253
Empiric Treatment for Acute HIV in the ED
NaSingle-groupOpen-labelTreatment
Summary
An acceptance and feasibility study for immediate ART initiation and storage of laboratory specimens for individuals with suspected acute HIV infection who are diagnosed in one of the 7 participating emergency rooms
Timeline
- Start
- 2019-10-14
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenofovir AF | Unknown | 25 mg | — |
| Subject | bictegravir | Small molecule | 50 mg | — |
| Subject | emtricitabine | Other / unclassified | 200 mg | — |
Indications
No indication recorded.